![]() |
|
Systematic (IUPAC) name | |
---|---|
2-(2-ethyl-2,3-dihydro-1-benzofuran-2-yl)-4,5-dihydro-1H-imidazole
|
|
Clinical data | |
Routes of administration |
Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 89197-32-0 ![]() |
ATC code | none |
PubChem | CID 72016 |
ChemSpider | 65015 ![]() |
UNII | G00490L21H ![]() |
ChEMBL | CHEMBL57895 ![]() |
Chemical data | |
Formula | C13H16N2O |
Molar mass | 216.28 g/mol |
|
|
|
|
(verify) |
Efaroxan is an α2-adrenergic receptor antagonist[1] and antagonist of the imidazoline receptor.
See also
References
- ^ Chopin P, Colpaert FC, Marien M (February 1999). "Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway". J. Pharmacol. Exp. Ther. 288 (2): 798–804. PMID 9918591.
|